Tapewire

NYSE · USD

PFE

PFIZER INC

Export transactions ↓
Tapewire entity
2863
SEC CIK
0000078003
Parsed reports
4,941

Last 12 months

Inside the activity.

3 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202601
Jul 202600
Aug 202631
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
October 13, 2026 Filed Oct 14, 2026 20:48 UTC
BOURLA ALBERTDirector · Chairman & CEO
GrantPhantom Stock Units SSP · Derivative 71 $28.37 $2,014.27
Disclosure

SEC source: 0001225208-26-008409 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 783,981

Underlying: Common Stock · 71 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
September 30, 2026 Filed Oct 1, 2026 22:04 UTC
BOURLA ALBERTDirector · Chairman & CEO
GrantPhantom Stock Units SSP · Derivative 21 $28.52 $598.92
Disclosure

SEC source: 0001225208-26-008044 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 783,888

Underlying: Common Stock · 21 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
September 25, 2026 Filed Sep 29, 2026 18:26 UTC GrantPhantom Stock Units · Derivative 1,613.185 $28.67 $46,250.01
Disclosure

SEC source: 0001225208-26-007988 · doc4.xml · derivative · entry 1

Echevarria Joseph · CIK 0001633137 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 169,739.319

Underlying: Common Stock · 1,613.185 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
September 25, 2026 Filed Sep 29, 2026 18:26 UTC GrantPhantom Stock Units · Derivative 1,307.987 $28.67 $37,499.99
Disclosure

SEC source: 0001225208-26-007989 · doc4.xml · derivative · entry 1

Buckley Mortimer J · CIK 0002041310 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,039.756

Underlying: Common Stock · 1,307.987 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
September 25, 2026 Filed Sep 29, 2026 18:25 UTC GrantPhantom Stock Units · Derivative 1,351.587 $28.67 $38,750.00
Disclosure

SEC source: 0001225208-26-007986 · doc4.xml · derivative · entry 1

Quincey James · CIK 0001561264 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,670.847

Underlying: Common Stock · 1,351.587 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
September 25, 2026 Filed Sep 29, 2026 18:25 UTC GrantPhantom Stock Units · Derivative 1,743.983 $28.67 $49,999.99
Disclosure

SEC source: 0001225208-26-007987 · doc4.xml · derivative · entry 1

NARAYEN SHANTANU · CIK 0001224154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 205,648.823

Underlying: Common Stock · 1,743.983 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
September 25, 2026 Filed Sep 29, 2026 18:25 UTC GrantPhantom Stock Units · Derivative 1,307.987 $28.67 $37,499.99
Disclosure

SEC source: 0001225208-26-007984 · doc4.xml · derivative · entry 1

Taraporevala Cyrus · CIK 0001454920 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 38,805.658

Underlying: Common Stock · 1,307.987 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
September 25, 2026 Filed Sep 29, 2026 18:25 UTC GrantPhantom Stock Units · Derivative 1,569.585 $28.67 $45,000.00
Disclosure

SEC source: 0001225208-26-007985 · doc4.xml · derivative · entry 1

SMITH JAMES C · CIK 0001611777 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,210.086

Underlying: Common Stock · 1,569.585 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
September 15, 2026 Filed Sep 16, 2026 19:17 UTC
BOURLA ALBERTDirector · Chairman & CEO
GrantPhantom Stock Units SSP · Derivative 22 $27.55 $606.10
Disclosure

SEC source: 0001225208-26-007840 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 783,985

Underlying: Common Stock · 22 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
August 31, 2026 Filed Sep 1, 2026 21:54 UTC
BOURLA ALBERTDirector · Chairman & CEO
GrantPhantom Stock Units SSP · Derivative 21 $28.46 $597.66
Disclosure

SEC source: 0001225208-26-007499 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 784,012

Underlying: Common Stock · 21 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
August 14, 2026 Filed Aug 17, 2026 22:15 UTC
BOURLA ALBERTDirector · Chairman & CEO
GrantPhantom Stock Units SSP · Derivative 22 $26.79 $589.38
Disclosure

SEC source: 0001225208-26-007145 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 785,060

Underlying: Common Stock · 22 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
August 12, 2026 Filed Aug 12, 2026 20:04 UTC
BOURLA ALBERTDirector · Chairman & CEO
PurchaseCommon Stock 38,000 $26.34 $1,000,920.00
Disclosure

SEC source: 0001225208-26-007083 · doc4.xml · nonDerivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 429,173

Read SEC document
August 05, 2026 Filed Aug 5, 2026 20:02 UTC PurchaseCommon Stock 37,632 $25.52 $960,368.64
Disclosure

SEC source: 0001225208-26-006943 · doc4.xml · nonDerivative · entry 1

Buckley Mortimer J · CIK 0002041310 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,632

Read SEC document
August 05, 2026 Filed Aug 5, 2026 20:03 UTC PurchaseCommon Stock 39,231 $25.46 $998,821.26
Disclosure

SEC source: 0001225208-26-006944 · doc4.xml · nonDerivative · entry 1

BLAYLOCK RONALD E · CIK 0001214686 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,938

Read SEC document
August 05, 2026 Filed Aug 6, 2026 15:26 UTC
DAMICO JENNIFER B.SVP & Controller
SaleCommon Stock 3,278 $25.40 $83,261.20
Disclosure

SEC source: 0001225208-26-007004 · doc4.xml · nonDerivative · entry 1

DAMICO JENNIFER B. · CIK 0001805617 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 28,611

Read SEC document
July 31, 2026 Filed Aug 3, 2026 23:50 UTC
BOURLA ALBERTDirector · Chairman & CEO
GrantPhantom Stock Units SSP · Derivative 24 $25.01 $600.24
Disclosure

SEC source: 0001225208-26-006900 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 786,154

Underlying: Common Stock · 24 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
July 15, 2026 Filed Jul 16, 2026 22:17 UTC
BOURLA ALBERTDirector · Chairman & CEO
GrantPhantom Stock Units SSP · Derivative 24 $24.82 $595.68
Disclosure

SEC source: 0001225208-26-006638 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 772,901

Underlying: Common Stock · 24 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
July 09, 2026 Filed Jul 13, 2026 19:43 UTC
BOURLA ALBERTDirector · Chairman & CEO
GrantPhantom Stock Units SSP · Derivative 84 $24.25 $2,037.00
Disclosure

SEC source: 0001225208-26-006587 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 772,938

Underlying: Common Stock · 84 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
June 30, 2026 Filed Jul 1, 2026 19:50 UTC
BOURLA ALBERTDirector · Chairman & CEO
GrantPhantom Stock Units SSP · Derivative 25 $24.08 $602.00
Disclosure

SEC source: 0001225208-26-006273 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 772,979

Underlying: Common Stock · 25 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 19:09 UTC GrantPhantom Stock Units · Derivative 1,543.845 $24.29 $37,500.00
Disclosure

SEC source: 0001225208-26-006255 · doc4.xml · derivative · entry 1

Taraporevala Cyrus · CIK 0001454920 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,941.287

Underlying: Common Stock · 1,543.845 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 19:10 UTC GrantPhantom Stock Units · Derivative 1,595.307 $24.29 $38,750.01
Disclosure

SEC source: 0001225208-26-006256 · doc4.xml · derivative · entry 1

Quincey James · CIK 0001561264 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,993.957

Underlying: Common Stock · 1,595.307 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 19:11 UTC GrantPhantom Stock Units · Derivative 1,852.614 $24.29 $44,999.99
Disclosure

SEC source: 0001225208-26-006257 · doc4.xml · derivative · entry 1

SMITH JAMES C · CIK 0001611777 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 182,886.001

Underlying: Common Stock · 1,852.614 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 19:16 UTC GrantPhantom Stock Units · Derivative 2,058.46 $24.29 $49,999.99
Disclosure

SEC source: 0001225208-26-006258 · doc4.xml · derivative · entry 1

NARAYEN SHANTANU · CIK 0001224154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 200,879.336

Underlying: Common Stock · 2,058.46 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 19:18 UTC GrantPhantom Stock Units · Derivative 1,904.076 $24.29 $46,250.01
Disclosure

SEC source: 0001225208-26-006259 · doc4.xml · derivative · entry 1

Echevarria Joseph · CIK 0001633137 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 165,631.508

Underlying: Common Stock · 1,904.076 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
June 26, 2026 Filed Jun 30, 2026 19:18 UTC GrantPhantom Stock Units · Derivative 1,543.845 $24.29 $37,500.00
Disclosure

SEC source: 0001225208-26-006260 · doc4.xml · derivative · entry 1

Buckley Mortimer J · CIK 0002041310 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,335.128

Underlying: Common Stock · 1,543.845 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
June 15, 2026 Filed Jun 16, 2026 20:21 UTC
BOURLA ALBERTDirector · Chairman & CEO
GrantPhantom Stock Units SSP · Derivative 23 $26.00 $598.00
Disclosure

SEC source: 0001225208-26-006072 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 772,772

Underlying: Common Stock · 23 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
June 09, 2026 Filed Jun 10, 2026 23:58 UTC
DAMICO JENNIFER B.SVP & Controller
SaleCommon Stock 2,000 $25.70 $51,400.00
Disclosure

SEC source: 0001225208-26-005911 · doc4.xml · nonDerivative · entry 1

DAMICO JENNIFER B. · CIK 0001805617 · SVP & Controller

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,397

Read SEC document
May 29, 2026 Filed Jun 1, 2026 23:42 UTC
BOURLA ALBERTDirector · Chairman & CEO
GrantPhantom Stock Units SSP · Derivative 23 $26.18 $602.14
Disclosure

SEC source: 0001225208-26-005687 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 772,789

Underlying: Common Stock · 23 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
May 15, 2026 Filed May 18, 2026 20:39 UTC
BOURLA ALBERTDirector · Chairman & CEO
GrantPhantom Stock Units SSP · Derivative 24 $25.33 $607.92
Disclosure

SEC source: 0001225208-26-005449 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 773,297

Underlying: Common Stock · 24 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
April 30, 2026 Filed May 4, 2026 20:20 UTC
BOURLA ALBERTDirector · Chairman & CEO
GrantPhantom Stock Units SSP · Derivative 22 $26.70 $587.40
Disclosure

SEC source: 0001225208-26-004835 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 760,229

Underlying: Common Stock · 22 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:22 UTC GrantPhantom Stock Units · Derivative 7,686.539 $26.67 $205,000.00
Disclosure

SEC source: 0001225208-26-004650 · doc4.xml · derivative · entry 1

Taraporevala Cyrus · CIK 0001454920 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,826.086

Underlying: Common Stock · 7,686.539 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:22 UTC GrantPhantom Stock Units · Derivative 7,686.539 $26.67 $205,000.00
Disclosure

SEC source: 0001225208-26-004651 · doc4.xml · derivative · entry 1

SMITH JAMES C · CIK 0001611777 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 178,111.302

Underlying: Common Stock · 7,686.539 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:22 UTC GrantPhantom Stock Units · Derivative 7,686.539 $26.67 $205,000.00
Disclosure

SEC source: 0001225208-26-004652 · doc4.xml · derivative · entry 1

Quincey James · CIK 0001561264 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 85,004.077

Underlying: Common Stock · 7,686.539 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:23 UTC GrantPhantom Stock Units · Derivative 7,686.539 $26.67 $205,000.00
Disclosure

SEC source: 0001225208-26-004654 · doc4.xml · derivative · entry 1

NARAYEN SHANTANU · CIK 0001224154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 195,611.68

Underlying: Common Stock · 7,686.539 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:37 UTC GrantPhantom Stock Units · Derivative 7,686.539 $26.67 $205,000.00
Disclosure

SEC source: 0001225208-26-004657 · doc4.xml · derivative · entry 1

Echevarria Joseph · CIK 0001633137 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 161,084.684

Underlying: Common Stock · 7,686.539 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:37 UTC GrantPhantom Stock Units · Derivative 7,686.539 $26.67 $205,000.00
Disclosure

SEC source: 0001225208-26-004658 · doc4.xml · derivative · entry 1

Desmond-Hellmann Susan · CIK 0001507911 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,635.605

Underlying: Common Stock · 7,686.539 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:37 UTC GrantPhantom Stock Units · Derivative 7,686.539 $26.67 $205,000.00
Disclosure

SEC source: 0001225208-26-004660 · doc4.xml · derivative · entry 1

BLAYLOCK RONALD E · CIK 0001214686 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,012.66

Underlying: Common Stock · 7,686.539 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:37 UTC GrantPhantom Stock Units · Derivative 7,686.539 $26.67 $205,000.00
Disclosure

SEC source: 0001225208-26-004659 · doc4.xml · derivative · entry 1

Buckley Mortimer J · CIK 0002041310 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,391.124

Underlying: Common Stock · 7,686.539 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:39 UTC GrantPhantom Stock Units · Derivative 7,686.539 $26.67 $205,000.00
Disclosure

SEC source: 0001225208-26-004661 · doc4.xml · derivative · entry 1

LITTMAN DAN R. · CIK 0001733004 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,533.568

Underlying: Common Stock · 7,686.539 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:39 UTC GrantPhantom Stock Units · Derivative 7,686.539 $26.67 $205,000.00
Disclosure

SEC source: 0001225208-26-004662 · doc4.xml · derivative · entry 1

NORA JOHNSON SUZANNE M · CIK 0001310264 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,982.649

Underlying: Common Stock · 7,686.539 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

Read SEC document
April 23, 2026 Filed Apr 27, 2026 22:40 UTC GrantPhantom Stock Units · Derivative 7,686.539 $26.67 $205,000.00
Disclosure

SEC source: 0001225208-26-004663 · doc4.xml · derivative · entry 1

Gottlieb Scott · CIK 0001411359 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 57,001.814

Underlying: Common Stock · 7,686.539 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · shares: Granted pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Unit Award Plan for Non-Employee Directors.

F3 · derivative.exercise_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

F3 · derivative.expiration_date: These units represent deferred director's compensation that are settled in cash or common stock at the director's election, following the reporting person's retirement from the Board of Directors.

Read SEC document
April 15, 2026 Filed Apr 17, 2026 17:16 UTC
BOURLA ALBERTDirector · Chairman & CEO
GrantPhantom Stock Units SSP · Derivative 22 $27.19 $598.18
Disclosure

SEC source: 0001225208-26-004554 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 760,070

Underlying: Common Stock · 22 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
April 14, 2026 Filed Apr 16, 2026 20:31 UTC
BOURLA ALBERTDirector · Chairman & CEO
GrantPhantom Stock Units SSP · Derivative 911 $27.11 $24,697.21
Disclosure

SEC source: 0001225208-26-004532 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 760,090

Underlying: Common Stock · 911 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
March 31, 2026 Filed Apr 1, 2026 21:52 UTC
BOURLA ALBERTDirector · Chairman & CEO
GrantPhantom Stock Units SSP · Derivative 21 $28.08 $589.68
Disclosure

SEC source: 0001225208-26-004140 · doc4.xml · derivative · entry 1

BOURLA ALBERT · CIK 0001595703 · Director · Chairman & CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 759,049

Underlying: Common Stock · 21 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.

Read SEC document
March 27, 2026 Filed Mar 31, 2026 00:18 UTC GrantPhantom Stock Units · Derivative 1,386.834 $27.04 $37,499.99
Disclosure

SEC source: 0001225208-26-004084 · doc4.xml · derivative · entry 1

Buckley Mortimer J · CIK 0002041310 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,704.585

Underlying: Common Stock · 1,386.834 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
March 27, 2026 Filed Mar 31, 2026 00:19 UTC GrantPhantom Stock Units · Derivative 1,710.429 $27.04 $46,250.00
Disclosure

SEC source: 0001225208-26-004085 · doc4.xml · derivative · entry 1

Echevarria Joseph · CIK 0001633137 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 153,398.145

Underlying: Common Stock · 1,710.429 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
March 27, 2026 Filed Mar 31, 2026 00:20 UTC GrantPhantom Stock Units · Derivative 1,433.062 $27.04 $38,750.00
Disclosure

SEC source: 0001225208-26-004087 · doc4.xml · derivative · entry 1

Quincey James · CIK 0001561264 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,317.538

Underlying: Common Stock · 1,433.062 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
March 27, 2026 Filed Mar 31, 2026 00:19 UTC GrantPhantom Stock Units · Derivative 1,849.112 $27.04 $49,999.99
Disclosure

SEC source: 0001225208-26-004086 · doc4.xml · derivative · entry 1

NARAYEN SHANTANU · CIK 0001224154 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,925.141

Underlying: Common Stock · 1,849.112 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
March 27, 2026 Filed Mar 31, 2026 00:21 UTC GrantPhantom Stock Units · Derivative 1,664.201 $27.04 $45,000.00
Disclosure

SEC source: 0001225208-26-004088 · doc4.xml · derivative · entry 1

SMITH JAMES C · CIK 0001611777 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 170,424.763

Underlying: Common Stock · 1,664.201 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document
March 27, 2026 Filed Mar 31, 2026 00:22 UTC GrantPhantom Stock Units · Derivative 1,386.834 $27.04 $37,499.99
Disclosure

SEC source: 0001225208-26-004089 · doc4.xml · derivative · entry 1

Taraporevala Cyrus · CIK 0001454920 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 27,139.547

Underlying: Common Stock · 1,386.834 shares

Expires not disclosed

F1 · derivative.exercise_price: Each unit represents one phantom share of common stock.

F2 · derivative.exercise_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

F2 · derivative.expiration_date: These units represent deferred director's compensation (including dividend equivalents thereon) that are settled in cash or common stock at the director's election following the reporting person's retirement from the Board of Directors.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.